Advertisement

World Journal of Surgery

, Volume 42, Issue 9, pp 2815–2824 | Cite as

A Novel Indocyanine Green Fluorescence-Guided Video-Assisted Technique for Sentinel Node Biopsy in Breast Cancer

  • Luca Sorrentino
  • Alessandra Sartani
  • Gaia Pietropaolo
  • Daniela Bossi
  • Serena Mazzucchelli
  • Marta Truffi
  • Diego Foschi
  • Fabio Corsi
Original Scientific Report

Abstract

Background

The equipment to detect indocyanine green (ICG) fluorescence for sentinel lymph node (SLN) biopsy in breast cancer is not widely accessible nor optimal. The fluorescence appears as a poorly defined white shine on a black background, and dimmed lighting is required. The aim of this study was to assess the feasibility, accuracy and healthcare costs of a novel approach for SLN biopsy by a video-assisted ICG-guided technique.

Methods

The technique for detecting SLN was radioisotope (RI) in 194 cases, video-assisted ICG-guided in 70 cases and a combined method in 71 cases. In the video-assisted ICG group, a full HD laparoscopic system equipped with xenon lamps was used for a laser-free detection of ICG within a colored and magnified high-resolution image.

Results

Detection of ICG fluorescence using a laparoscope with a near-infrared filter provided a highly defined and colored image during SLN biopsy. SLN was identified in 100% of patients in all groups. Multiple SLNs were identified in 0.5% of RI patients, in 12.9% of ICG patients and in 14.1% of ICG + RI patients (p < 0.0001). In ICG + RI group, 95.1% of lymph nodes were radioactive and 92.7% were fluorescent. Operative times and healthcare costs were equivalent between groups.

Conclusions

Video-assisted ICG-guided technique is a feasible and surgeon-friendly method for SLN biopsy, with equivalent efficacy compared to RI, providing an accurate staging of the axilla.

Notes

Acknowledgements

This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors. All the authors reported no acknowledgements.

Compliance with ethical standards

Conflict of interest

All the authors reported no conflict of interest.

References

  1. 1.
    Cody HS (1999) Sentinel lymph node mapping in breast cancer. Breast Cancer 6:13–22CrossRefPubMedGoogle Scholar
  2. 2.
    Peek MC, Charalampoudis P, Anninga B et al (2017) Blue dye for identification of sentinel nodes in breast cancer and malignant melanoma: a systematic review and meta-analysis. Future Oncol 13:455–467CrossRefPubMedGoogle Scholar
  3. 3.
    Ahmed M, Purushotham AD, Douek M (2014) Novel techniques for sentinel lymph node biopsy in breast cancer: a systematic review. Lancet Oncol 15:e351–e362CrossRefPubMedGoogle Scholar
  4. 4.
    Ahmed M, Purushotham AD, Horgan K et al (2015) Meta-analysis of superficial versus deep injection of radioactive tracer and blue dye for lymphatic mapping and detection of sentinel lymph nodes in breast cancer. Br J Surg 102:169–181CrossRefPubMedGoogle Scholar
  5. 5.
    Niebling MG, Pleijhuis RG, Bastiaannet E et al (2016) A systematic review and meta-analyses of sentinel lymph node identification in breast cancer and melanoma, a plea for tracer mapping. Eur J Surg Oncol 42:466–473CrossRefPubMedGoogle Scholar
  6. 6.
    Alhussini MA, Awad AT, Ashour MH et al (2016) Breast cancer sentinel node detection: an alternative solution for centers lacking nuclear technology. Breast Care 11:265–268CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Derossis AM, Fey JV, Cody HS et al (2003) Obesity influences outcome of sentinel lymph node biopsy in early-stage breast cancer. J Am Coll Surg 197:896–901CrossRefPubMedGoogle Scholar
  8. 8.
    Morrow M, Rademaker AW, Bethke KP et al (1999) Learning sentinel node biopsy: results of a prospective randomized trial of two techniques. Surgery 126:714–720CrossRefPubMedGoogle Scholar
  9. 9.
    Kitai T, Inomoto T, Miwa M et al (2005) Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer 12:211–215CrossRefPubMedGoogle Scholar
  10. 10.
    Sugie T, Kassim KA, Takeuchi M et al (2010) A novel method for sentinel lymph node biopsy by indocyanine green fluorescence technique in breast cancer. Cancers 2:713–720CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Sugie T, Ikeda T, Kawaguchi A et al (2017) Sentinel lymph node biopsy using indocyanine green fluorescence in early-stage breast cancer: a meta-analysis. Int J Clin Oncol 22:11–17CrossRefPubMedGoogle Scholar
  12. 12.
    Troyan SL, Kianzad V, Gibbs-Strauss SL et al (2009) The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping. Ann Surg Oncol 16:2943–2952CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Hirche C, Murawa D, Mohr Z et al (2010) ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer. Breast Cancer Res Treat 121:373–378CrossRefPubMedGoogle Scholar
  14. 14.
    Wishart GC, Loh SW, Jones L et al (2012) A feasibility study (ICG-10) of indocyanine green (ICG) fluorescence mapping for sentinel lymph node detection in early breast cancer. Eur J Surg Oncol 38:651–656CrossRefPubMedGoogle Scholar
  15. 15.
    Toh U, Iwakuma N, Mishima M et al (2015) Navigation surgery for intraoperative sentinel lymph node detection using Indocyanine green (ICG) fluorescence real-time imaging in breast cancer. Breast Cancer Res Treat 153:337–344CrossRefPubMedGoogle Scholar
  16. 16.
    Coufal O, Fait V (2016) Use of indocyanine green and the HyperEye system for detecting sentinel lymph nodes in breast cancer within a population of European patients: a pilot study. World J Surg Oncol 14:299CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Martin RC, Edwards MJ, Wong SL et al (2000) Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study. For the University of Louisville Breast Cancer Study Group. Surgery 128(2):139–144CrossRefPubMedGoogle Scholar
  18. 18.
    Tong M, Guo W, Gao W (2014) Use of fluorescence imaging in combination with patent blue dye versus patent blue dye alone in sentinel lymph node biopsy in breast cancer. J Breast Cancer 17:250–255CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Samorani D, Fogacci T, Panzini I et al (2015) The use of indocyanine green to detect sentinel nodes in breast cancer: a prospective study. Eur J Surg Oncol 41:64–70CrossRefPubMedGoogle Scholar
  20. 20.
    Sugie T, Kinoshita T, Masuda N et al (2016) Evaluation of the clinical utility of the ICG fluorescence method compared with the radioisotope method for sentinel lymph node biopsy in breast cancer. Ann Surg Oncol 23:44–50CrossRefPubMedGoogle Scholar
  21. 21.
    Zhang X, Li Y, Zhou Y et al (2016) Diagnostic performance of indocyanine green-guided sentinel lymph node biopsy in breast cancer: a meta-analysis. PLoS ONE 11:e0155597CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Guo J, Yang H, Wang S et al (2017) Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort study. World J Surg Oncol 15:196CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Boni L, David G, Mangano A et al (2015) Clinical applications of indocyanine green (ICG) enhanced fluorescence in laparoscopic surgery. Surg Endosc 29:2046–2055CrossRefPubMedGoogle Scholar
  24. 24.
    Jung SY, Kim SK, Kim SW et al (2014) Comparison of sentinel lymph node biopsy guided by the multimodal method of indocyanine green fluorescence, radioisotope, and blue dye versus the radioisotope method in breast cancer: a randomized controlled trial. Ann Surg Oncol 21:1254–1259CrossRefPubMedGoogle Scholar
  25. 25.
    Grischke EM, Röhm C, Hahn M et al (2015) ICG fluorescence technique for the detection of sentinel lymph nodes in breast cancer: results of a prospective open-label clinical trial. Geburtshilfe Frauenheilkd 75:935–940CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2018

Authors and Affiliations

  • Luca Sorrentino
    • 1
  • Alessandra Sartani
    • 1
  • Gaia Pietropaolo
    • 1
  • Daniela Bossi
    • 2
  • Serena Mazzucchelli
    • 3
  • Marta Truffi
    • 3
  • Diego Foschi
    • 1
    • 3
  • Fabio Corsi
    • 2
    • 3
  1. 1.Surgery Division, ASST Fatebenefratelli-SaccoLuigi Sacco University HospitalMilanItaly
  2. 2.Surgery Department, Breast UnitICS Maugeri S.p.A. SBPaviaItaly
  3. 3.Department of Biomedical and Clinical Sciences “Luigi Sacco”University of MilanMilanItaly

Personalised recommendations